Histopathological characteristics of breast cancer and evaluation of ER alpha and Her-2neu using immunohistochemical and RT-PCR techniques

Histopathological characteristics of breast cancer and evaluation of ER alpha and Her-2neu using immunohistochemical and RT-PCR techniques

Background and purpose: Oestrogen receptor (ER) and HER (human epidermal growth factor receptor) family signaling pathways are fundamental to guide treatment and determine prognosis. Categorizing breast cancer tumors as ER and Her-2 positive or negative is usually performed by immunohistochemistry (...

Full description

Bibliographic Details
Main Authors:	Eman El-Abd, Cecil A. Matta, Manal Sheta, Yasser El-Kerm, Shimaa Sakr
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2014-09-01
Series:	Alexandria Journal of Medicine
Subjects:	Human epidermal growth factor receptor (HER) Immunohistochemistry (IHC) Invasive ductal carcinoma Not otherwise specified (IDC NOS) Estrogen receptor (ER)
Online Access:	http://www.sciencedirect.com/science/article/pii/S209050681400030X

Similar Items

Symptomatic ovarian steroid cell tumor not otherwise specified in a post-menopausal woman
by: Neha Sood, et al.
Published: (2016-06-01)

Detección inmunohistoquímica del receptor del factor de crecimiento epidérmico: revisión de algunos aspectos técnicos relacionados
by: Rancés Blanco Santana, et al.

HER-2/NEU Ekspresyonun Saptanmasinda İmmunohistokimyasal ve Fish Yöntemi Arasında Diskordansin Belirlenmesi Önemli midir?
by: Berna Bozkurt DUMAN, et al.
Published: (2014-07-01)

HER2 overexpression is a putative diagnostic and prognostic biomarker for late-stage colorectal cancer in North African patients
by: Eman A. Abdul Razzaq, et al.
Published: (2021-01-01)

Micro RNA-21 expression levels in invasive breast carcinoma with a non-invasive component
by: Petrović Nina, et al.
Published: (2015-01-01)

Recurrent breast cancer diagnosis delayed by COVID-19 pandemic
by: Hanna K. Thompson, BS, et al.
Published: (2021-06-01)

Evaluation of Immunohistochemistry Technique in Detecting HER2 Overexpression in Invasive Ductal Breast Carcinoma Using Fluorescence in-situ Hybridization Method
by: Azar Baradaran, et al.
Published: (2016-03-01)

Prognosis significance of HER-2/neu overexpression/amplification in Chinese patients with curatively resected gastric cancer after the ToGA clinical trial
by: Zhou Fei, et al.
Published: (2012-12-01)

Single-day HER2neu amplification assessment using chip-based digital PCR in formalin-fixed paraffin-embedded breast carcinoma tissue
by: Shah PS, et al.
Published: (2018-07-01)

EFFECT OF AGE ON PROGNOSIS IN DIFFERENT MOLECULAR SUBTYPES OF FEMALE BREAST CARCINOMA
by: Naveed Sharif, et al.
Published: (2015-09-01)

The Discordance Between HER-2/NEU Expression Assessed by Immunohistochemistry (IHC) and Fluorescence in Situ Hybridization (FISH): Is It Important to Detect?
by: Berna Bozkurt Duman, et al.
Published: (2014-02-01)

The susceptibility to infection by Leishmania panamensis and the sensitivity to drugs differ according to the macrophage type Expresión de los receptores hormonales (RE/RP) y sobreexpresión de la proteína HER-2/neu en carcinoma ductal infiltrante
by: Olga T. Anteliz B., et al.
Published: (2011-08-01)

Comparison of the influence of human epidermal growth factor receptor 2/neu on the markers of aggression in gastric adenocarcinomas and ductal carcinoma breast
by: Anant Kulkarni, et al.
Published: (2016-01-01)

Intrinsic subtyping of breast cancer and its relevance with clinico-pathological features and outcomes in patients from North India: a single center experience
by: S Harish, et al.
Published: (2020-01-01)

A Clinicopathological Study of Benign Phyllodes Tumour of Breast with Emphasis on Unusual Features
by: Kishori Moni Panda, et al.
Published: (2016-07-01)

Recurrent breast cancer diagnosis delayed by COVID-19 pandemic
by: Hanna K. Thompson, BS, et al.
Published: (2021-09-01)

Successful Treatment of Primary Cutaneous Peripheral T-Cell Lymphoma Presenting Acquired Ichthyosis with Oral Bexarotene Monotherapy
by: Kayo Tanita, et al.
Published: (2017-04-01)

Malignant Ovarian Steroid Cell Tumor, Not Otherwise Specified, Causes Virilization in a 4-Year-Old Girl: A Case Report and Literature Review
by: Takaharu Yoshimatsu, et al.
Published: (2020-04-01)

Effect of yoga in the treatment of eating disorders: A single-blinded randomized controlled trial with 6-months follow-up
by: Kari Ebbesen Karlsen, et al.
Published: (2018-01-01)

Steroid cell tumor not otherwise specified of bilateral ovaries: A rare cause of post menopausal virilization
by: Samanthi M. A. Cooray, et al.
Published: (2013-01-01)

NEW INDICATORS OF HSP27 FUNCTIONAL STATE IN BREAST CANCER CELLS WITH DIFFERENT VARIANTS OF HER2/NEU-STATUS
by: E. V. Kaigorodova, et al.
Published: (2016-02-01)

Common and unique multimodal covarying patterns in autism spectrum disorder subtypes
by: Shile Qi, et al.
Published: (2020-11-01)

HER2 Testing in Invasive Breast Cancer: A Comparison Between Immunohistochemistry and Fluorescence In Situ Hybridization Assays
by: Maryam Moradi Chaleshtori, et al.
Published: (2020-08-01)

Potential Role for a Panel of Immunohistochemical Markers in the Management of Endometrial Carcinoma
by: Amany Salama, et al.
Published: (2019-05-01)

Peripheral T-cell lymphoma, not otherwise specified
by: Kunal Kishor Jha, et al.
Published: (2017-01-01)

Refractory Septic Shock due to Underlying Immunocompromised Disease: A Case of Fatal Peripheral T-Cell Lymphoma Not Otherwise Specified in a Young Hispanic Woman
by: Kishore Kumar, et al.
Published: (2018-06-01)

The naturalistic follow-up of pervasive developmental disorders–not otherwise specified cases
by: Sezen Köse, et al.
Published: (2017-07-01)

Pancreatic collision tumor of ductal adenocarcinoma and neuroendocrine tumor—A rare case report
by: Prajna Das, et al.
Published: (2021-01-01)

Invasive ductal breast carcinoma metastasis to the cervix: A case review and clinical correlation
by: E. Cochrane, et al.
Published: (2020-08-01)

Immunohistochemical analysis of adipokine and adipokine receptor expression in the breast tumor microenvironment: associations of lower leptin receptor expression with estrogen receptor-negative status and triple-negative subtype
by: Adana A. M. Llanos, et al.
Published: (2020-02-01)

Correlation of histological grade with Estrogen, Progesterone and HER2/neu reactivity in breast cancer
by: Girishma Shrestha, et al.
Published: (2019-09-01)

Gallbladder Adenocarcinoma, Potential Target for Anti-Her-2 Therapy
by: Ghazi Zafar, et al.
Published: (2020-08-01)

Lipidated Peptidomimetic Ligand-Functionalized HER2 Targeted Liposome as Nano-Carrier Designed for Doxorubicin Delivery in Cancer Therapy
by: Himgauri Naik, et al.
Published: (2021-03-01)

Immunohistochemical Expression of HER2/neu, Ki-67 and MUC1 in Benign and Malignant Gall Bladder Lesions and its Association with Clinicopathological Parameters
by: Rania G Roshdy, et al.
Published: (2021-02-01)

Non-Classic Myeloproliferative Neoplasms: Are We Really Aware of These Rare Diseases in Daily Practice
by: Serdal Korkmaz
Published: (2017-08-01)

CURRENT MORPHOLOGICAL AND IMMUNOHISTOCHEMICAL FEATURES OF MALE BREAST CANCER
by: A C Tutovan, et al.
Published: (2019-07-01)

An embodied belonging
by: Karin Eli
Published: (2014-12-01)

Relationship between MMP-11 Expression in Invasive Ductal Breast Carcinoma with its Clinicopathologic Parameters
by: Farshad Naghshvar, et al.
Published: (2017-04-01)

Discordance of the estrogen receptor and HER-2/neu in breast cancer from primary lesion to first and second metastatic site
by: Lower EE, et al.
Published: (2017-08-01)

Breast Mammographic Density: Stromal Implications on Breast Cancer Detection and Therapy
by: Patricia Fernández-Nogueira, et al.
Published: (2020-03-01)